Image

Latissimus Dorsi Activity During Different Exercises

Latissimus Dorsi Activity During Different Exercises

Recruiting
18-40 years
All
Phase N/A

Powered by AI

Overview

This single-visit, laboratory study will quantify latissimus dorsi activation during standardized band/body-weight exercises commonly used in rehabilitation (e.g., standing bent-over row, inferior glide, seated press-up, body-lifting). Healthy, physically active adults (18-40 y; Tegner ≥5) will perform three repetitions per exercise with metronome-paced phases (≈3 s concentric, 3 s isometric, 3 s eccentric), 5-s rest between repetitions and 2-min between exercises; load will be individualized to reach OMNI RPE 6-8. Surface EMG (TeleMyo DTS; Noraxon) will be recorded from the latissimus dorsi (medial and lateral) and selected synergists (teres major, infraspinatus, posterior deltoid, triceps); electrode placement will follow SENIAM recommendations. Signals will be band-pass filtered (20-500 Hz), rectified, RMS-smoothed with a 100-ms window, and normalized to %MVIC using standardized MVC tests; exercise/MVC order will be randomized to limit bias. The primary outcome is mean normalized EMG amplitude per exercise; secondary outcomes include peak amplitude and categorical activation levels (low ≤20% MVIC, moderate 21-40%, high 41-60%, very high \>60%). The study involves minimal risk (possible mild skin irritation under electrodes and transient post-exercise fatigue).

Description

The latissimus dorsi (LD) originates from the spinous processes of the lower six thoracic vertebrae and the thoracolumbar fascia/iliac crest, and-together with the teres major-attaches to the medial lip of the intertubercular groove of the humerus. Functionally, LD contributes to shoulder adduction, internal rotation, and extension, linking the upper limb to the trunk. Alongside the rotator cuff, prevention of superior translation of the humeral head may be provided by the glenohumeral adductors (pectoralis major and LD) acting as humeral head depressors via a medio-inferior vector created by their tendon orientation. From an osteokinematic perspective, LD may protect against subacromial pain by facilitating inferior glide of the humeral head on the glenoid.

Selecting an appropriate strengthening exercise is critical to restore muscle performance and functional arm elevation in patients with shoulder injury or dysfunction. The literature emphasizes exercises targeting activation of the rotator cuff and scapulothoracic muscles that contribute to functional elevation. Surface electromyography (sEMG) is commonly used to guide exercise selection and progression by quantifying a muscle's contribution across different exercises, thereby enabling evidence-based advancement in strengthening programs.

However, much of the existing LD literature centers on lateral pull-down variations, with limited data for rehabilitation-relevant tasks such as low row, inferior glide, bent-over row (with trunk flexion), seated press-up, and body-lifting. Focusing on a single exercise limits clinical decision-making for shoulder rehabilitation (exercise selection and progression). Therefore, to support a scientific, evidence-based progression for LD strengthening in rehabilitation, this study was planned to obtain comprehensive sEMG data across multiple exercises.

Aim: To examine LD EMG activation levels during different exercises and determine between-exercise differences.

Eligibility

Inclusion Criteria:

  • Age 18-40 years
  • No range-of-motion restriction at the glenohumeral joint
  • No shoulder, cervical, or lumbar region complaints/injury within the past 6 months
  • No systemic or neurological disease
  • Competent to consent and provides written informed consent
  • Tegner Activity Scale ≥ 5

Exclusion Criteria:

  • Body mass index (BMI) \> 25 kg/m²

Study details
    Muscle Activation

NCT07297771

Hacettepe University

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.